Patent details

Basic Information

Publication number:

EP1292303

PCT Application Number:

PCT/US/2001/005577

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP019110782

PCT Publication Number:

WO/2002/067935

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

A STABLE PHARMACEUTICAL FORMULATION COMPRISING TORSEMIDE MODIFICATION II

French Title of Invention:

FORMULATION PHARMACEUTIQUE STABLE CONTENANT DU TORSEMIDE MODIFICATION II

German Title of Invention:

EINE STABILE PHARMAZEUTISCHE FORMULIERUNG DIE TORSEMID MODIFIKATION II ENTHÄLT

SPC Number:

Dates

Filing date:

21/02/2001

Grant date:

12/05/2004

EP Publication Date:

12/05/2004

PCT Publication Date:

06/09/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/03/2003

EP B1 Publication Date:

12/05/2004

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

21/02/2021

Renunciation date:

Revocation date:

21/02/2005

Annulment date:

Owner

From:

21/02/2001

 

 

Name:

TEVA PHARMACEUTICAL INDUSTRIES LTD.

Address:

5 Basel Street, P.O. Box 3190, 49131 Petah Tiqva, Israel (IL)

Inventor

1

Name:

ARONHIME Judith

Address:

Israel (IL)

2

Name:

TENENGAUZER Ruth

Address:

Israel (IL)

3

Name:

LEIBOVICI Minutza

Address:

Israel (IL)

4

Name:

KOPEL Mira

Address:

Israel (IL)

5

Name:

KORDOVA Marco

Address:

Israel (IL)

Classification

Main IPC Class:

A61K 31/44;

Filing date	Document type	Number of pages